Top Navigation

Archive | Gastrointestinal Health

Pain Management, Todays Practitioner

#3 TOP READ / CASE STUDY: Melatonin for Reflux Disease

In this second part of a special report on alternatives to proton pump inhibitors, Today’s Practitioner explores the science behind melatonin.  As the use of PPIs comes in questions for some, there are a number of integrative care doctors seeking alternatives. Long before FDA issued warnings about PPIs, Melvyn Werbach MD described a case study […]

Continue Reading
PPI, GERD, Todays Practitioner

#4 TOP READ / SPECIAL REPORT: Why Americans are Pushing for Alternatives to PPIs

By Kimberly Lord Stewart Patients and physicians are getting heartburn on how best to treat digestive health issues. Though the use proton pump inhibitors (PPIs) has dramatically risen in the last decade, opinions are quickly changing on how to best treat digestive disorders like heartburn and gastroesophageal reflux disease (GERD). Safety concerns (more…) RELATED ARTICLES […]






Continue Reading
Alessio-Fasano-University-of-Maryland

Why Joe Pizzorno Says You Need to Know Alessio Fasano

  Introduction It’s not often that you hear a doctor use words like “remarkable” and “most clinically important lectures ever,” when referring to a conference lecture. Those were Joe Pizzorno’s ND words from a lecture by Alessio Fasano, MD at the Institute for Functional Medicine (IFM) conference in Dallas, Texas in May 2013. Pizzorno, Editor […]






Continue Reading
pasta copy

New ELISA/ELISPOT Blood Test Shows Promise for Celiac Diagnosis

  News Celiac disease affects an estimated 1 in 133 Americans, or about 1% of the population, has celiac disease. As many as 83% of Americans who have celiac disease are undiagnosed or misdiagnosed with other conditions. On average, most (more…) RELATED ARTICLES Why Joe Pizzorno Says You Need to Know Alessio Fasano






Continue Reading
Probiotic probiotic yoghurt drink, nutritional supplement

The Use Of Probiotics In The Treatment Of Irritable Bowel Syndrome: Two Case Reports

CASE  STUDY Irritable Bowel Syndrome (IBS) affects as much as 20% of the adult population in the US,2 and is the leading cause of work absenteeism, second only to the common cold. IBS affects an estimated 15 million individuals each year in the US, which represents 12% of the primary (more…) RELATED ARTICLES











Continue Reading

For the Assessment of Intestinal Permeability, Size Matters

The purpose of this review is to demonstrate that an intestine leaky to small molecules can be impermeable to large antigenic molecules. The author proposes that the permeability of the epithelium to very small sugar molecules such as lactulose/mannitol—used for the past 50 years to gauge intestinal permeability… (more…) RELATED ARTICLES Bromelain Limits Airway Inflammation […]











Continue Reading

Powered by Quadshot